GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » 5-Year EBITDA Growth Rate

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings 5-Year EBITDA Growth Rate?

CTT Pharmaceutical Holdings's EBITDA per Share for the three months ended in Jun. 2018 was $-0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate falls into.



CTT Pharmaceutical Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


CTT Pharmaceutical Holdings  (OTCPK:CTTH) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


CTT Pharmaceutical Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Executives
Albert C Zapanta director PO BOX 2020, SPRINGDALE AR 72765
William Thomson director 390 BAY ST, SUITE 1102, TORONTO ONTARIO A6 M5H 2Y2